← Eichor
Condition: Advanced Adenoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Advanced Adenoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Tango Therapeutics, Inc. · NCT05732831Collection of Samples USOPTIVAL Study
Phase N/A · 16 location(s) · Universal Diagnostics · NCT04792684Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
Phase N/A · 9 location(s) · ADVANCED MARKER DISCOVERY S.L. · NCT06889883Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Phase 1/Phase 2 · 12 location(s) · Vivace Therapeutics, Inc · NCT04665206First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05381792Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
NA · 13 location(s) · University Hospital, Bordeaux · NCT07299071Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Phase 2/Phase 3 · 117 location(s) · Exelixis · NCT06943755Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Phase 1/Phase 2 · 66 location(s) · Genmab · NCT05579366St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
Phase N/A · 6 location(s) · University of British Columbia · NCT05402696Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
Phase 1 · 1 location(s) · University of Chicago · NCT06663072A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1 · 1 location(s) · BridGene Biosciences Inc. · NCT06452160Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
NA · 1 location(s) · University of Chicago · NCT07126509CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Phase 1 · 1 location(s) · A&G Pharmaceutical Inc. · NCT05627960A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene M
NA · 2 location(s) · Chinese University of Hong Kong · NCT05592886Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 · 25 location(s) · Bristol-Myers Squibb · NCT05245500A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/Phase 2 · 5 location(s) · 7 Hills Pharma, LLC · NCT06362369A Study of VET3-TGI in Patients With Solid Tumors
Phase 1 · 7 location(s) · KaliVir Immunotherapeutics · NCT06444815Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
Phase N/A · 6 location(s) · Zhejiang University · NCT06220617FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413Diagnostic Accuracy of M3 in Predicting Colorectal Advanced Adenoma Recurrence (M3-AA)
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05144152China Colorectal Cancer Screening Trial 1 (C-Cost1)
NA · 7 location(s) · Zhejiang University · NCT07090291Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06141369A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma
Phase N/A · 1 location(s) · Tianjin Medical University Second Hospital · NCT06031636
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.